These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 855970)

  • 1. [Circulating anticoagulants in disseminated lupus erythematosus. Apropos of 3 cases].
    Krulik M; Tobelem G; Audebert AA; Mougeot-Martin M; Debray J
    Ann Med Interne (Paris); 1977 Jan; 128(1):57-62. PubMed ID: 855970
    [No Abstract]   [Full Text] [Related]  

  • 2. [Report of two cases of circulating anticoagulant directed against factor xi (author's transl)].
    Vila M; Monasterio J; Arangüena PV; Valentin P; Pico M; Triginer J
    Sangre (Barc); 1978; 23(2):202-9. PubMed ID: 653555
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-factor XI circulating anticoagulant (author's transl)].
    Durán Suárez JR; Vilaseca J; Ordeig J; Triginer J
    Sangre (Barc); 1981; 26(5-A):631-7. PubMed ID: 7323919
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rheumatoid arthritis and circulating antifactor 8 anticoagulant of immunoglobulin (IgG) nature. Apropos of a case treated with azathioprine].
    Soria C; Soria J; Girard M; Lejeay A; Kahn MF; Guérin C; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Mar; 38(3):227-34. PubMed ID: 5559721
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal platelet function by acquired circulating factor VIII inhibitor in a patient with systemic lupus erythematosus.
    Cortellaro M; Pogliani E; Cofrancesco E
    Haematologica; 1977 Jun; 62(3):241-9. PubMed ID: 408237
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired factor XI inhibitor in systemic lupus erythematosus--case report and literature review.
    Bortoli R; Monticielo OA; Chakr RM; Palominos PE; Rohsig LM; Kohem CL; Xavier RM; Brenol JC
    Semin Arthritis Rheum; 2009 Aug; 39(1):61-5. PubMed ID: 18519152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lupus anticoagulant: an increasingly used marker].
    Castañeda Sanz S; Herrero-Beaumont G; Tornero Molina J; Aguado García JM; Outeiriño J
    Rev Clin Esp; 1985 Jun; 177(1):1-6. PubMed ID: 3929341
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on a circulating anticoagulant in systemic lupus erythematosus: evidence for inhibition of the function of activated plasma thromboplastin antecedent (factor XIa).
    Krieger H; Leddy JP; Breckenridge RT
    Blood; 1975 Aug; 46(2):189-97. PubMed ID: 237589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired inhibitors of blood coagulation.
    Feinstein DI; Rapaport SI
    Prog Hemost Thromb; 1972; 1():75-95. PubMed ID: 4569725
    [No Abstract]   [Full Text] [Related]  

  • 10. [Circulating anticoagulants with antiprothrombinase activity in systemic lupus erythematosus (author's transl)].
    Gazengel C; Dougados M; Kremp O; Tron F; Noël LH; Jungers P
    Nouv Presse Med; 1980 Sep; 9(33):2325-8. PubMed ID: 7433022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation and acute disseminated lupus erythematosus. Apropos of 25 cases].
    Godeau P; Herreman G; Raby C; Levassor M
    Sem Hop; 1977 Mar; 53(10):609-12. PubMed ID: 194314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunocoagulopathy (lupus anticoagulant) with severe hemorrhagic diathesis in systemic lupus erythematosus].
    Wysocka K; Kiczak J; Pozorska D
    Wiad Lek; 1977 Jul; 30(14):1129-34. PubMed ID: 888437
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquired factor XI deficiency in systemic lupus erythematosus.
    Vercellotti GM; Mosher DF
    Thromb Haemost; 1982 Dec; 48(3):250-2. PubMed ID: 7164014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin changes in SLE.
    Shoenfeld Y; Pick AI; Danziger Y; Kalaczi I; Frolichman R; Pinkhas J
    Ann Allergy; 1977 Aug; 39(2):99-101. PubMed ID: 889159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-elastin antibodies in systemic lupus erythematosus].
    Gmiński J; Poborski W; Kasprzak A; Drózdz M; Kardaszewicz E; Machalski M
    Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):513-5. PubMed ID: 2287568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enhanced activity of diminished blood clotting factors in inborn blood coagulation defects].
    Mingers AM; Mietens C; Ströder J
    Thromb Diath Haemorrh; 1971 Jun; 25(2):316-31. PubMed ID: 5568051
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
    Follea G; Ffrench P; Trzeciak MC; Dechavanne M
    Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic defect due to acquired circulating inhibitors against lipid procoagulant and factor VIII.
    Pechet L; Snyder LM; Chesney C; Colman RW
    Thromb Diath Haemorrh; 1974 Sep; 32(1):90-104. PubMed ID: 4548947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating anticoagulants].
    Krulik M; Debray J; Vergoz D; Yvart J
    Sem Hop; 1971 Jun; 47(28):1820-7. PubMed ID: 4327218
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acquired coagulation inhibitors. 10 cases (author's transl)].
    Alexandre P; André E; Briquel ME; Labrude P; Streiff F
    Nouv Presse Med; 1980 Oct; 9(39):2901-4. PubMed ID: 7443421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.